Related Experiment Videos
Summary
Undescended testes (cryptorchidism) increase testicular cancer risk. Orchiectomy is recommended over orchiopexy for unilateral cryptorchidism to prevent cancer. Regular surveillance is crucial for late-descending testes.
Area of Science:
- Urology
- Oncology
- Pediatric Surgery
Background:
- Cryptorchidism, or undescended testes, is a known risk factor for testicular germ cell tumors.
- Management of cryptorchidism has implications for cancer development and treatment.
Purpose of the Study:
- To analyze the outcomes of testicular germ cell tumors in patients with cryptorchidism, evaluating the impact of surgical correction.
- To provide recommendations for the management of cryptorchidism in relation to testicular cancer prevention.
Main Methods:
- Retrospective review of 137 patients with cryptorchidism and testicular germ cell tumors treated between 1934 and 1976.
- Analysis of tumor histology, treatment of cryptorchidism (spontaneous descent, orchiopexy, hormonal therapy, or uncorrected), and survival rates.
- Evaluation of adjuvant therapies such as lymphatic irradiation and chemotherapy in survivors.
Main Results:
- Five-year survival rates were similar for corrected (61%) and uncorrected (63%) cryptorchidism cases.
- Pure seminoma had a higher survival rate (79%) compared to other germinal carcinomas (50%).
- Testicular tumors developing despite correction were predominantly germinal carcinomas (72%).
Conclusions:
- Unilateral cryptorchidism associated with testicular atrophy should be treated with orchiectomy, not orchiopexy, to prevent ipsilateral carcinogenesis.
- Periodic surveillance is recommended for cryptorchid patients with late-descended testes, particularly after a 20-year latent period, for early cancer detection.